Search

Search Constraints

You searched for: Author/Creator Hamamoto, Junko

Search Results

1. A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer. (December 2021)

2. Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9‐induced mouse model of lung adenocarcinoma. Issue 4 (17th December 2014)

3. Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations. (January 2019)

4. Intracellular levels of reactive oxygen species correlate with ABT‐263 sensitivity in non‐small‐cell lung cancer cells. Issue 10 (5th August 2020)

5. Methylation‐induced downregulation of TFPI‐2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non‐small‐cell lung carcinoma. Issue 1 (8th December 2014)

6. Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms. (May 2018)